Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo ...

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...

CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...

Understand the cash flow statement for Akebia Therapeutics, Inc. (AKBA), learn where the money comes from and how the company spends it.

Asahi Kasei has developed the TA Series of Sunfort dry film photoresist as a new product designed to meet growing demand in the field of advanced semiconductor packages used in applications such ...

Akebia Therapeutics, Inc. (AKBA) earnings report: revenue, EPS, surprise, history, news and analysis. Skip to content Home page Seeking Alpha - Power to Investors ...

Real time quote data is not available at this time.

AKBA U.S.: Nasdaq Akebia Therapeutics Inc. + Watchlist Alert AKBA US After Hours Last Updated: May 30, 2025 7:56 p.m. EDT Delayed quote $ 3.0300 0.00 0.00% After Hours Volume: 40.45K Close Chg Chg ...

As of 13:59:28 GMT-4. Market open.